Host: |
HEK293 |
Note: |
STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Recombinant-Human CD20-protein was developed from hek293. For use in research applications. |
Conjugation: |
Unconjugated |
Formulation: |
0.2 Mu m filtered PBS solution, pH7.2. |
Storage Instruction: |
Can be stored in working aliquots at 2°C-8°C C for one month, or at-20°C to-70°C for 1 year. Avoid repeated freeze/thaw cycles. NA |
Endotoxin: |
Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg). NA |
Gene Symbol: |
MS4A1 |
Gene ID: |
931 |
Uniprot ID: |
CD20_HUMAN |
Immunogen Region: |
Cytoplasmic domain |
Immunogen: |
Optimized DNA sequence encoding cytoplasmic domain of human CD20 including a N-terminal 6His tag was expressed in HEK293 cells. NA |
Tissue Specificity | Expressed on B-cells. |
Post Translational Modifications | Phosphorylated on serines and threonines in resting B-cells. Protein kinase C/PKC can use CD20 as substrate. |
Function | B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes. Functions as a store-operated calcium (SOC) channel component promoting calcium influx after activation by the B-cell receptor/BCR. |
Protein Name | B-Lymphocyte Antigen Cd20B-Lymphocyte Surface Antigen B1Bp35Leukocyte Surface Antigen Leu-16Membrane-Spanning 4-Domains Subfamily A Member 1Cd Antigen Cd20 |
Cellular Localisation | Cell MembraneMulti-Pass Membrane ProteinLipid-AnchorConstitutively Associated With Membrane Rafts |
Alternative Protein Names | B-Lymphocyte Antigen Cd20 proteinB-Lymphocyte Surface Antigen B1 proteinBp35 proteinLeukocyte Surface Antigen Leu-16 proteinMembrane-Spanning 4-Domains Subfamily A Member 1 proteinCd Antigen Cd20 proteinMS4A1 proteinCD20 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance